AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2865187
Drug: Standard-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose oral contraceptive
Trial: 27779454
Drug: Lercanidipine hydrochloride
RxNorm normalized name: lercanidipine hydrochloride
DrugBank: Lercanidipine (DB00528)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine hydrochloride 10 mg/d
Trial: 27779454
Drug: Felodipine sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine sustained-release tablets 5 mg/d
Trial: 19146603
Drug: Topical formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical formulation containing 3.75% glycerol and 1.25% hydrolyzed jojoba esters (K-20W)
Trial: 19146603
Drug: Glycerol alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol alone in a standard base skin care lotion
Trial: 15380582
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of electron beam radiotherapy (10 Gy)
Trial: 3024959
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (TRH) administered at a daily dose of 0.5-1 mg intravenously or intramuscularly for 1-4 weeks.
Trial: 28384261
Drug: Miltefosine via
RxNorm normalized name: Miltefosine
DrugBank: Miltefosine (DB09031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Miltefosine via caregiver Directly Observed Therapy (cDOT)
Trial: 27070526
Drug: Group-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based cognitive behavioral therapy (12 sessions)
Trial: 16579084
Drug: Chinese medicines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicines for promoting blood circulation to remove blood stasis
Trial: 8584071
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) at a dosage higher than 100 mg/day
Trial: 25224595
Drug: Oral cryotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cryotherapy (OC) combined with Caphosol()
Trial: 23448434
Drug: Dexmedetomidine (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (starting dose, 0.4 μg·kg(‐1) ·h(‐1))
Trial: 23448434
Drug: Midazolam (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (starting dose, 0.1 mg·kg(‐1) ·h(‐1))
Trial: 21091269
Drug: Clevidipine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clevidipine infusion starting at 2 mg/h, doubled every 3 min as needed to a maximum of 32 mg/h, continued for at least 18 h (96 h maximum).
Trial: 16675705
Drug: Plain polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain polysaccharide vaccine
Trial: 15573657
Drug: 0.5‐mg/kg‐body weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5‐mg/kg‐body weight midazolam mixed in strawberry syrup via the oral‐transmucosal route
Trial: 15573657
Drug: Syrup diluted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup diluted with normal saline
Trial: 9625287
Drug: Acarbose 25
RxNorm normalized name: acarbose 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 25 mg t.i.d.
Trial: 9625287
Drug: Acarbose 50
RxNorm normalized name: acarbose 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 50 mg t.i.d.
Trial: 9625287
Drug: Acarbose 200
RxNorm normalized name: Acarbose
DrugBank: Acarbose (DB00284)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acarbose 200 mg t.i.d.
Trial: 28580833
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (500 mg, 3 times a day for 2 weeks)
Trial: 28580833
Drug: Placebo (starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (starch supplement, 500 mg)
Trial: 19030909
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose (2 g) of n-3 PUFA
Trial: 19030909
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (6.6 g) of n-3 PUFA
Trial: 11401423
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline (PTX) with 100 mg carbamazepine (CBZ) at 22:00 h
Trial: 11401423
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg carbamazepine (CBZ) alone at 22:00 h
Trial: 11401423
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pentoxifylline (PTX) with 100 mg carbamazepine (CBZ) at 10:00 h
Trial: 11401423
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg carbamazepine (CBZ) alone at 10:00 h
Trial: 9563208
Drug: Sumatriptan 25
RxNorm normalized name: sumatriptan 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 25 mg and 50 mg
Trial: 7517103
Drug: Individual/Direct therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual/Direct therapy
Trial: 7517103
Drug: Group/Consultation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group/Consultation therapy
Trial: 28888268
Drug: Spironolactone 25mg
RxNorm normalized name: SPIRONOLACTONE 25MG TAB
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone 25mg once daily
Trial: 28888268
Drug: Chlorthalidone 25mg
RxNorm normalized name: CHLORTHALIDONE 25MG TAB
DrugBank: Chlorthalidone (DB00310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 25mg once daily
Trial: 25600720
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg/day (decreased by 100 mg every 5 days after the first 5 days)
Trial: 25600720
Drug: Prednisone 75
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone 75 mg/day (tapered off every 5 days after the first 5 days)
Trial: 22179922
Drug: SBC Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBC Group (15 mcg clonidine added to bupivacaine 2.5 mg and sufentanil 5 mcg)
Trial: 22179922
Drug: SB Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB Group (bupivacaine 2.5 mg and sufentanil 5 mcg)
Trial: 16794456
Drug: High-flavanol cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flavanol cocoa beverage (446 mg of total flavanols)
Trial: 16794456
Drug: Low-flavanol cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flavanol cocoa beverage (43 mg of total flavanols)
Trial: 11074900
Drug: Oral fluconazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluconazole, 400 mg/d
Trial: 10423939
Drug: Itraconazole, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole, 200 mg twice daily
Trial: 4073078
Drug: Ticarcillin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticarcillin plus clavulanic acid (3.1 g every six hours via intravenous infusion)
Trial: 4073078
Drug: Moxalactam (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxalactam (2.0 g every eight hours via intravenous infusion)
Trial: 30957444
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy and speech rehabilitation exercises (control group)
Trial: 26010037
Drug: Epidural injections
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injections with corticosteroid plus lidocaine
Trial: 26010037
Drug: Epidural injections
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injections with lidocaine alone
Trial: 21672339
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus rosiglitazone (4 mg once daily, orally)
Trial: 16433920
Drug: Budesonide/formoterol (320/9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol (320/9 microg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes, total dose 1280/36 microg)
Trial: 16433920
Drug: Formoterol (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol (9 microg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes, total dose 36 microg)
Trial: 16433920
Drug: Budesonide/formoterol and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol and Formoterol (both treatments)
Trial: 14973093
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg once daily) plus high-selenium baker's yeast (200 microg once daily)
Trial: 14973093
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg once daily) plus placebo
Trial: 8175445
Drug: lonidamine (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lonidamine (450 mg p.o. in three divided daily doses)
Trial: 3364627
Drug: Budesonide (nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (nasal spray, 400 micrograms/d)
Trial: 3364627
Drug: Methylprednisolone acetate
RxNorm normalized name: methylprednisolone acetate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone acetate (i.m. injection of 80 mg)
Trial: 24073529
Drug: 500 microg-F/g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 microg-F/g with 0.25%CaGP (500 CaGP)
Trial: 24073529
Drug: 1,100 microg-F/g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,100 microg-F/g (1,100) dentifrice
Trial: 24073529
Drug: 500 microg-F/g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 microg-F/g (500) dentifrice
Trial: 22020609
Drug: Local retropharyngeal
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local retropharyngeal steroid (triamcinolone and morcellized collagen sponge)
Trial: 22020609
Drug: Local retropharyngeal
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local retropharyngeal steroid
Trial: 9209176
Drug: Very-low-energy diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-low-energy diet with increased iron content (27 mg/d)
Trial: 9209176
Drug: Very-low-energy diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-low-energy diet with recommended dietary allowance of iron (18 mg/d)
Trial: 8491505
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg/day for 7 days
Trial: 3030678
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg topically administered beclomethasone dipropionate (BDP)
Trial: 3030678
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg betamethasone phosphate (BMT)
Trial: 17089229
Drug: Ketamine 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.4 mg/kg before incision
Trial: 17089229
Drug: Saline before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline before incision, Ketamine 0.4 mg/kg after incision
Trial: 9252161
Drug: Ribavirin 600
RxNorm normalized name: ribavirin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin 600 mg given orally twice daily for 36 weeks
Trial: 2891285
Drug: Ionic contrast
RxNorm normalized name: IONIC CONTRAST MEDIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ionic contrast agent (sodium meglumine diatrizoate)
Trial: 2891285
Drug: Nonionic contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonionic contrast agent (iopamidol)
Trial: 29476444
Drug: Upward dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upward dose titration of pregabalin
Trial: 29476444
Drug: No upward
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No upward dose titration (inadequately titrated patients)
Trial: 25371633
Drug: Intravitreal Ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal Ranibizumab followed by grid laser treatment (Group 1)
Trial: 25371633
Drug: Intravitreal Bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal Bevacizumab followed by grid laser treatment (Group 2)
Trial: 20925997
Drug: Metformin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin with clomiphene citrate (CC) and human menopausal gonadotrophin (HMG)
Trial: 20925997
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with clomiphene citrate (CC) and human menopausal gonadotrophin (HMG)
Trial: 11954953
Drug: Propranolol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.2 mg/kg, n=9)
Trial: 9892882
Drug: THC (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC (10 mg/m2 of body surface area)
Trial: 7740291
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg ASA orally daily (Group A)
Trial: 6586277
Drug: AMSA Regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMSA Regimen I (120 mg/m2/day for 5 days)
Trial: 6586277
Drug: AMSA Regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMSA Regimen II (60 mg/m2/day for 10 days)
Trial: 30565741
Drug: Zoledronate-coated implant
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronate-coated implant
Trial: 30565741
Drug: Uncoated implant
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Uncoated implant (Control)
Trial: 21326328
Drug: Adherence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence therapy (AT)
Trial: 9516597
Drug: Dose-dense paclitaxel-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-dense paclitaxel-containing therapy (A->T->C regimen)
Trial: 7827298
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc supplementation (300 mg zinc aspartate, equal to 60 mg elemental zinc per day) for 4 weeks
Trial: 25834076
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (Group 1)
Trial: 25834076
Drug: Regular, ongoing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular, ongoing therapy (Group 3)
Trial: 25834076
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injections (Group 2)
Trial: 23833857
Drug: Group LVHC:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LVHC: 0.5 ml/kg bupivacaine 0.375% (1.875 mg/kg)
Trial: 23833857
Drug: Group C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C: 1 ml/kg bupivacaine 0.25% (2.5 mg/kg)
Trial: 21079463
Drug: anesthetic spray
RxNorm normalized name: Americaine 20% Topical Anesthetic Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anesthetic spray
Trial: 21079463
Drug: placebo spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo spray
Trial: 21079463
Drug: anesthetic intradermal
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anesthetic intradermal injection
Trial: 21079463
Drug: placebo intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo intradermal injection
Trial: 21079463
Drug: control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control group with no local anesthetic agent
Trial: 15082697
Drug: 0.625 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/d of conjugated equine estrogen (CEE)
Trial: 8843494
Drug: Inositol (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inositol (6 gm daily)
Trial: 3865493
Drug: Cefaclor 20
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor 20 mg/kg body weight b.i.d. for 10 days
Trial: 3865493
Drug: Cefaclor treatment
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor treatment
Trial: 30930801
Drug: EMDR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR therapy (n = 71)
Trial: 30930801
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU) (n = 71)
Trial: 24518774
Drug: Statin drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin drug use
Trial: 16953394
Drug: Glucosamine hydrochloride
RxNorm normalized name: Glucosamine Hydrochloride
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine hydrochloride at a daily dose of 1,500 mg for 12 weeks along with conventional medication
Trial: 16953394
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 12 weeks along with conventional medication
Trial: 12398260
Drug: Modafinil 50
RxNorm normalized name: armodafinil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 50 mg x 24 h(‐1)
Trial: 12398260
Drug: Modafinil 150
RxNorm normalized name: armodafinil 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 150 mg x 24 h(‐1)
Trial: 12398260
Drug: Modafinil 300
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 300 mg x 24 h(‐1)
Trial: 9915885
Drug: SC-FOS 10
RxNorm normalized name: FOS-APV
DrugBank: Fosamprenavir (DB01319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SC-FOS 10 g/d
Trial: 9915885
Drug: SC-FOS 20
RxNorm normalized name: FOS-APV
DrugBank: Fosamprenavir (DB01319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SC-FOS 20 g/d
Trial: 9915885
Drug: SC-FOS 0
RxNorm normalized name: FOS-APV
DrugBank: Fosamprenavir (DB01319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SC-FOS 0 g/d (Control)
Trial: 9915885
Drug: SC-FOS 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC-FOS 2.5 g/d (Control)
Trial: 9915885
Drug: SC-FOS 5
RxNorm normalized name: FOS-APV
DrugBank: Fosamprenavir (DB01319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SC-FOS 5 g/d (Control)
Trial: 7766747
Drug: Bisacodyl (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisacodyl (10 mg)
Trial: 7766747
Drug: Lactose (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactose (45 g)
Trial: 38177
Drug: Prednisone (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (high-dose suppressive therapy)
Trial: 38177
Drug: Prednisone (prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (prophylactic dose)
Trial: 38177
Drug: Sulfasalazine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfasalazine (high dose)
Trial: 38177
Drug: Sulfasalazine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfasalazine (low dose)
Trial: 8392345
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparins (LMWH) and Unfractionated heparin (UFH)
Trial: 30871639
Drug: lambda‐cyhalothrin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lambda‐cyhalothrin with pheromone + residual insecticide spray (PI)
Trial: 29534330
Drug: Liquid micelles
RxNorm normalized name: Douxo Micellar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid micelles (500 mg vineatrol, 30 mg trans-resveratrol, 75 mg trans-ε-viniferin)
Trial: 29534330
Drug: Native powder
RxNorm normalized name: Castanea sative leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Native powder (500 mg vineatrol, 30 mg trans-resveratrol, 75 mg trans-ε-viniferin)
Trial: 27137199
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (40 international units)
Trial: 23434570
Drug: Adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 40 mg every other week plus methotrexate 7.5 mg/week (increased to 20 mg/week within 2 months) and intra-articular triamcinolone
Trial: 10365000
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (group Cl, n = 46)
Trial: 10365000
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (group Cl)
Trial: 7554701
Drug: 2400 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2400 mg/day felbamate
Trial: 7261663
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no topical thrombin)
Trial: 30629046
Drug: Caffeine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3 mg·kg body mass)
Trial: 23812464
Drug: Ibandronate (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate (150 mg orally every month)
Trial: 17725176
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg probenecid 3 times daily for 2 days
Trial: 9764982
Drug: Alpha-interferon plus
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alpha-interferon plus ofloxacin (600 mg daily)